drugset / Trial / NCT05274893

A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer

NCT05274893

Phase 1 Unknown 28 enrolled CSPC Ouyi Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelOther

Summary

This is a multi-center, open-label, pharmacokinetic comparison study of SYHX2011 and Abraxane® in patients with advanced breast cancers after single IV infusion.

Timeline

Start
2022-03-31
Primary completion
2022-09-30
Completion
2022-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule 260 mg/m2 Intravenous
Subject SYHX2011 Unknown 260 mg/m2 Intravenous

Indications